ZIMV Stock Overview
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ZimVie Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.05 |
| 52 Week High | US$20.91 |
| 52 Week Low | US$6.52 |
| Beta | 2.01 |
| 1 Month Change | -2.49% |
| 3 Month Change | -8.39% |
| 1 Year Change | 99.13% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -42.68% |
Recent News & Updates
Recent updates
ZimVie: Shrinking Its Way To Profitability
Feb 12ZimVie Inc. (NASDAQ:ZIMV) Stock Catapults 93% Though Its Price And Business Still Lag The Industry
Dec 19
ZimVie Inc.'s (NASDAQ:ZIMV) Shares Bounce 27% But Its Business Still Trails The Industry
Apr 17ZimVie: Disappointing Guidance Prompts Caution
Aug 25ZimVie Q2 Non-GAAP EPS beats, revenue down Y/Y, guidance reduced
Aug 10ZimVie: Undervalued Spin-Off
Jul 05ZimVie: Spin-Off Of Dental And Spine Units Of Zimmer Biomet
Apr 23Shareholder Returns
| ZIMV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.3% | -2.9% | -3.2% |
| 1Y | 99.1% | -3.7% | 19.3% |
Return vs Industry: ZIMV exceeded the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: ZIMV exceeded the US Market which returned 19.3% over the past year.
Price Volatility
| ZIMV volatility | |
|---|---|
| ZIMV Average Weekly Movement | 7.9% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ZIMV's share price has been volatile over the past 3 months.
Volatility Over Time: ZIMV's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 2,600 | Vafa Jamali | www.zimvie.com |
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.
ZimVie Inc. Fundamentals Summary
| ZIMV fundamental statistics | |
|---|---|
| Market cap | US$421.65m |
| Earnings (TTM) | -US$56.05m |
| Revenue (TTM) | US$457.43m |
1.0x
P/S Ratio-7.8x
P/E RatioIs ZIMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZIMV income statement (TTM) | |
|---|---|
| Revenue | US$457.43m |
| Cost of Revenue | US$167.05m |
| Gross Profit | US$290.38m |
| Other Expenses | US$346.43m |
| Earnings | -US$56.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.06 |
| Gross Margin | 63.48% |
| Net Profit Margin | -12.25% |
| Debt/Equity Ratio | 124.3% |
How did ZIMV perform over the long term?
See historical performance and comparison